Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Abstract: Randomized clinical trial that aims to see the efficacy of photoneuromodulation for the treatment of negative symptoms of schizophrenia in patients refractory to transcranial direct current stimulation. In this group of 30 refractory volunteers, magnetic resonance spectroscopy will be performed before and after photoneuromodulation in a cross-over design.
Objectives: Effectiveness of photoneuromodulation in patients with schizophrenia. . Analysis of glutamate, Gaba and lactate in spectroscopy before and after stimulation (secondary) Sample: 30 volunteers with negative symptoms of schizophrenia refractory to treatment.
Method: clinical trial, cross-over randomized, double-blind, sham-controlled. PANSS negative symptoms subscale evaluation before and after the 10 photoneuromodulation sessions. Participants who are in the active group after the 10 photoneuromodulation sessions will go to the sham group and vice versa. They will perform magnetic resonance spectroscopy before the beginning, after the 10 sessions and again after the inversion of the groups (3 resonances per volunteer). The study will be a cross-over: half of participants will start at sham group and the other half at active group and invert groups after 10th day of stimulation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active Comparator: Active Photoneuromodulation | Active Comparator | Active stimulation with light fields as described in the intervention |
|
| Sham Comparator: Sham Photoneuromodulation | Sham Comparator | The blinding will be done with sham light, which consists of fields that do not reproduce light, but which have the same size and thickness as the true one. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Photoneuromodulation | Device | Treatments were administered daily for a period of 2 weeks (10 sessions) with a Light-Aid (Bright Photomedicine, SP, Brazil), continuous wave, 300 LED wavelength 850 nm) or with a placebo probe of the same appearance and display. The irradiation parameters created will be based on the disease, pain intensity and skin phototype. Each session has from 10 to 15 min, depending on skin phototype |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Subcale of PANSS | Continuos measure (score changes) | Weeks 0, 2 and 4 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in PANSS | Continuous measure (score changes). | Time Frame: Weeks 0, 1, 2, 3, 4, 6, 12] |
| Changes in WHOQOL | Continuous measure (score changes). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Leandro Valiengo, PhD | Study Principal Investigator | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Sao Paulo | São Paulo | São Paulo | Brazil |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
For the sham, the tip has LED light similar to the real one, but without generating the light field. The treatments will be administered in two sessions (active/sham) with a Light-Aid (Bright Photomedicine, SP, Brazil), continuous wave, 300 LEDs, wavelength of 850 nm). The irradiation parameters created will be based on the skin phototype according to the Fitzpatrick Scale.
The tip will be positioned in the prefrontal cortex (corresponding to F3 and F4 according to the 10-20 EEG system). This arrangement is commonly known as 'Bifrontal'. In each application, power densities between 45-50 mW/cm², frequency of 10 Hz, and total time of 10 to 15 minutes per session will be used. The tip used has a size equivalent to 70cm² each side.
Not provided
Not provided
We have two identical devices (a and b), that are equal in all aspects, but one of them is sham (does not product infrared (IR) light). As IR light is invisible for human eyes, neither the applicant of the procedure neither the participant will know if it is active or sham. All the participants had a code after randomization that does the allocation to sham or active. The machine (a or b) was chosen for an external researcher that has no contact with the team of the research.
|
| Time Frame: Weeks 0, 1, 2, 3, 4, 6, 12] |
| Changes in Brief Negative Symptom Scale (BNSS) | Continuous measure (score changes). | Time Frame: Weeks 0, 1, 2, 3, 4, 6, 12] |
| Changes in Calgary | Continuous measure (score changes). | Time Frame: Weeks 0, 1, 2, 3, 4, 6, 12] |
| Changes in SOFAS | Continuous measure (score changes). | Time Frame: Weeks 0,1, 2, 3, 4, 6, 12] |
| Changes in SANS | Continuous measure (score changes). | Time Frame: Weeks 0, 1, 2, 3, 4, 6, 12] |
| Changes in parameters of spectroscopy (lactate, glutamate, glicine and GABA) | Continuous measure (score changes). | Time Frame: Weeks 0, 2, 4] |